CN Patent

CN102395401B — 经由水凝胶塞的药物递送

Assigned to Incept LLC · Expires 2015-08-19 · 11y expired

What this patent protects

本发明涉及用于阻断或减少穿过人眼的泪点或泪小管的泪流并将药物递送至眼的医疗假体，其包含尺寸能通过泪点的脱水的共价交联的合成亲水聚合物水凝胶，该脱水的水凝胶吸收生理水而在截面宽度上膨胀至至少1mm且顺从地安装在泪小管中，该水凝胶包含分散在该水凝胶以释放至眼的治疗剂，该水凝胶当容许在体外于生理盐水中完全水合时具有以重量或体积计至少约50％的含水量。

USPTO Abstract

本发明涉及用于阻断或减少穿过人眼的泪点或泪小管的泪流并将药物递送至眼的医疗假体，其包含尺寸能通过泪点的脱水的共价交联的合成亲水聚合物水凝胶，该脱水的水凝胶吸收生理水而在截面宽度上膨胀至至少1mm且顺从地安装在泪小管中，该水凝胶包含分散在该水凝胶以释放至眼的治疗剂，该水凝胶当容许在体外于生理盐水中完全水合时具有以重量或体积计至少约50％的含水量。

Drugs covered by this patent

Patent Metadata

Patent number
CN102395401B
Jurisdiction
CN
Classification
—
Expires
2015-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Incept LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.